Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04901975 · ClinicalTrials.gov registry record · Phase 1
Fibrosis and the Fontan
A Phase 1 study of Single-ventricle, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 145
- Enrollment target
- 1
- Study location
NCT04901975 is a Phase 1 study of Single-ventricle that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 145 participants, above the 78-participant average among 17 other Single-ventricle trials with a reported enrollment target (86% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04901975, a Phase 1 study of Single-ventricle, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to non-invasively characterize the fibrotic consequences of single ventricle physiology, its possible solution and effect on lymphatics. This project investigates the response to acute imposition of Fontan hemodynamics by examining the interrelationship between liver and cardiac fibrosis/dysfunction and lymphatic congestion along with a pilot trial of the antifibrotic agent, spironolactone, to prevent these consequences and to determine if MRI can discern these differences. The combination of serum biomarkers and MRI form a powerful non-invasive tool in putting together this complicated web of dysfunction.
Conditions Studied
Interventions
- DRUG Spironolactone
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04901975
The ClinicalTrials.gov registry entry for NCT04901975 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 78-participant average among 17 other Single-ventricle trials with a reported enrollment target (86% higher). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Single-ventricle appearing as the primary indexed condition, and to 1 intervention - of which Spironolactone is the first listed.
NCT04901975 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04901975 about?
NCT04901975 is a clinical study titled "Fibrosis and the Fontan". The purpose of this study is to non-invasively characterize the fibrotic consequences of single ventricle physiology, its possible solution and effect on lymphatics. This project investigates the response to acute imposition of Fontan hemodynamics by examining the interrelationship between liver and...
What is the current status of trial NCT04901975?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 145 participants. The study started on 2021-02-11. Estimated completion is 2026-06-30.
What conditions does trial NCT04901975 study?
This clinical trial studies the following conditions: Single-ventricle.
What interventions are being tested in trial NCT04901975?
The interventions under investigation include: Spironolactone (DRUG).
Who is sponsoring clinical trial NCT04901975?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04901975 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Single-ventricle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PK/PD of Digoxin in Infants With SVHD
RECRUITING · Phase 1
-
Fontan Fitness Trial
RECRUITING · NA
-
Re-Energize Fontan
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
-
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
RECRUITING
-
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.